(Jerusalem, Israel) — [CBN News] The Ministry of Defense-run Israel Institute for Biological Research (IIBR) says two drugs designed to treat Gaucher’s disease could also be an effective treatment against COVID-19. (Image: via CBN News)
Gaucher’s disease is a genetic disorder that causes a fatty tissue to build up in certain organs, especially the liver and spleen. The fatty substances cause the organs to become enlarged and affect their function.
Researchers at the IIBR say two drugs used to treat Gaucher’s disease appear to inhibit viruses. The first drug is Cerdelga, which has already been approved by the US Food and Drug Administration. The second is Venglustat, which is in the process of being approved.
The scientists found that together, the drugs led to “a significant reduction in the replication capacity of the corona virus and to the destruction of the infected cell,” the Defense Ministry Spokesperson said in a statement.